Natus Medical (BABY) Tops Q2 EPS by 2c; Boosts FY15 EPS Outlook

Natus Medical (NASDAQ: BABY) reported Q2 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $91.9 million versus the consensus estimate of $90.83 million.

Natus Medical sees FY2015 EPS of $1.50-$1.52, versus prior guidance of $1.47-$1.51 and the consensus of $1.49.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c